Stem cell therapy for hepatocellular carcinoma and end-stage liver disease
Abstract Hepatocellular carcinoma (HCC) is a major health problem worldwide, especially for patients who are suffering from end-stage liver disease (ESLD). The ESLD is considered a great challenge for clinicians due to the limited chance for liver transplantation, which is the only curative treatmen...
| Autors principals: | , |
|---|---|
| Format: | Article |
| Idioma: | English |
| Publicat: |
SpringerOpen
2023-11-01
|
| Col·lecció: | Journal of the Egyptian National Cancer Institute |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1186/s43046-023-00194-z |